Title: Individualized dosimetry-based activity reduction of (90)Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy
Authors: Van Binnebeek, Sofie ×
Baete, Kristof
Vanbilloen, Bert
Terwinghe, Christelle
Koole, Michel
Mottaghy, Felix M
Clement, Paul
Mortelmans, Luc
Haustermans, Karin
Van Cutsem, Eric
Verbruggen, Alfons
Bogaerts, Kris
Verslype, Chris
Deroose, Christophe #
Issue Date: Jun-2014
Series Title: European Journal of Nuclear Medicine and Molecular Imaging vol:41 issue:6 pages:1141-1157
Article number: 10.1007/s00259-013-2670-x
Abstract: Assessment of kidney function evolution after (90)Y-DOTATOC peptide receptor radionuclide therapy (PRRT) with capped activity administration based on a 37-Gy threshold of biological effective dose (BED) to the kidney.
ISSN: 1619-7070
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Nuclear Medicine & Molecular Imaging
Department of Health and Technology - UC Leuven
Radiopharmaceutical Research
Laboratory of Experimental Radiotherapy
Laboratory of Experimental Oncology
Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat)
Clinical Digestive Oncology (+)
Clinical Residents Medicine
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
2014, EJNMMI, Van Binnebeek, Individualized dosimetry.pdf Published 1269KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science